High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial.

Source:http://linkedlifedata.com/resource/pubmed/id/14676787

Download in:

View as

General Info

PMID
14676787